Research Article

T Cell Response in Patients with Implanted Biological and Mechanical Prosthetic Heart Valves

Table 1

Clinical characteristics of patients.

CharacteristicsBiological prosthesis,
Mechanical prosthesis,

Age of patient at the time of primary surgery53 (49; 57)54 (28; 62)
Male/female ()7/181/6
%28/72 14.3/85.7
Duration of prosthesis functioning, month100 (83; 116)70 (64; 87)
Etiology of heart defect
 Rheumatic heart disease19 (76%)6 (85.7%)
 Infective endocarditis3 (12%)0
 Connective tissue dysplasia3 (12%)1 (14.3%)
Functioning of prosthesis
 Sustained18 (72%)7 (100%)
 Signs of malfunction7 (28%)0
Heart failure (NYHA)
 I9 (36%)2 (28.6%)
 IIА16 (64%)5 (71.4%)
Functional class of heart failure
 1 1 (4%)1 (14.3%)
 2 19 (76%)5 (71.4%)
 3 4 (16%)1 (14.3%)
 4 1 (4%)0
Cardiac dysrhythmia
 Sinus rhythm7 (28%)4 (57.1%)
 Paroxysmal atrial fibrillation5 (20%)3 (42.9%)
 Permanent atrial fibrillation 12 (48%)
 Ectopic heartbeat1 (4%)
Hypertonic disease7 (28%)4 (57.1%)
Type 2 diabetes mellitus3 (12%)0
Chronic ischemic heart disease 2 (8%)1 (14.3%)
Acute cerebrovascular accident3 (12%)1 (14.3%)
GI-tract diseases13 (52%)4 (57.1%)
Thyroid diseases2 (8%)1 (14.3%)
Diseases of the urinary system5 (20%)2 (28.6%)
Pulmonary diseases3 (12%)1 (14.1%)

Comments: , .